1. Home
  2. CRBU vs RGP Comparison

CRBU vs RGP Comparison

Compare CRBU & RGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • RGP
  • Stock Information
  • Founded
  • CRBU 2011
  • RGP 1996
  • Country
  • CRBU United States
  • RGP United States
  • Employees
  • CRBU N/A
  • RGP N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • RGP Business Services
  • Sector
  • CRBU Health Care
  • RGP Consumer Discretionary
  • Exchange
  • CRBU Nasdaq
  • RGP Nasdaq
  • Market Cap
  • CRBU 179.7M
  • RGP 155.0M
  • IPO Year
  • CRBU 2021
  • RGP 2006
  • Fundamental
  • Price
  • CRBU $2.68
  • RGP $4.95
  • Analyst Decision
  • CRBU Strong Buy
  • RGP Buy
  • Analyst Count
  • CRBU 3
  • RGP 2
  • Target Price
  • CRBU $6.67
  • RGP $6.00
  • AVG Volume (30 Days)
  • CRBU 1.3M
  • RGP 330.1K
  • Earning Date
  • CRBU 11-05-2025
  • RGP 10-08-2025
  • Dividend Yield
  • CRBU N/A
  • RGP 5.77%
  • EPS Growth
  • CRBU N/A
  • RGP N/A
  • EPS
  • CRBU N/A
  • RGP N/A
  • Revenue
  • CRBU $9,121,000.00
  • RGP $551,331,000.00
  • Revenue This Year
  • CRBU $8.06
  • RGP N/A
  • Revenue Next Year
  • CRBU N/A
  • RGP $12.36
  • P/E Ratio
  • CRBU N/A
  • RGP N/A
  • Revenue Growth
  • CRBU N/A
  • RGP N/A
  • 52 Week Low
  • CRBU $0.66
  • RGP $4.44
  • 52 Week High
  • CRBU $3.00
  • RGP $9.96
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 64.30
  • RGP 42.02
  • Support Level
  • CRBU $2.24
  • RGP $4.75
  • Resistance Level
  • CRBU $2.39
  • RGP $5.08
  • Average True Range (ATR)
  • CRBU 0.19
  • RGP 0.20
  • MACD
  • CRBU 0.04
  • RGP -0.04
  • Stochastic Oscillator
  • CRBU 94.75
  • RGP 15.00

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

Share on Social Networks: